IMR Stock Overview
A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Imricor Medical Systems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.94 |
| 52 Week High | AU$0.94 |
| 52 Week Low | AU$0.41 |
| Beta | 0.25 |
| 11 Month Change | 29.86% |
| 3 Month Change | 85.15% |
| 1 Year Change | 61.21% |
| 33 Year Change | -24.29% |
| 5 Year Change | -22.25% |
| Change since IPO | -35.07% |
Recent News & Updates
Recent updates
Shareholder Returns
| IMR | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 12.7% | 0.5% | 0.9% |
| 1Y | 61.2% | 14.8% | 18.4% |
Return vs Industry: IMR exceeded the Australian Medical Equipment industry which returned 14.8% over the past year.
Return vs Market: IMR exceeded the Australian Market which returned 18.4% over the past year.
Price Volatility
| IMR volatility | |
|---|---|
| IMR Average Weekly Movement | 12.0% |
| Medical Equipment Industry Average Movement | 9.4% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 17.5% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: IMR has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: IMR's weekly volatility (12%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | Steve Wedan | www.imricor.com |
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company’s principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning.
Imricor Medical Systems, Inc. Fundamentals Summary
| IMR fundamental statistics | |
|---|---|
| Market cap | AU$251.26m |
| Earnings (TTM) | -AU$31.18m |
| Revenue (TTM) | AU$1.27m |
198.1x
P/S Ratio-8.1x
P/E RatioIs IMR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IMR income statement (TTM) | |
|---|---|
| Revenue | US$824.32k |
| Cost of Revenue | US$1.74m |
| Gross Profit | -US$913.44k |
| Other Expenses | US$19.35m |
| Earnings | -US$20.26m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.075 |
| Gross Margin | -110.81% |
| Net Profit Margin | -2,458.30% |
| Debt/Equity Ratio | -126.8% |
How did IMR perform over the long term?
See historical performance and comparison